NAPLEX Practice Exam 2026 – Pharmacist Licensure Preparation in
Pharmacotherapy, Medication Use, Patient Assessment, Evidence-
Based Treatment Planning, Professional Practice, Pharmacy
Management and Clinical Decision-Making
Questions 1–48: Foundational Knowledge for Pharmacy Practice
Question 1
A 68-year-old patient with a creatinine clearance of 28 mL/min is prescribed a renally
eliminated antibiotic. Which pharmacokinetic parameter most directly determines the
required dose adjustment?
A. Volume of distribution
B. Elimination rate constant
C. Bioavailability
D. Protein binding
Correct Answer: B
Explanation: The elimination rate constant (ke) reflects the fraction of drug removed per unit
time and is directly proportional to clearance, which is impaired in renal dysfunction; dose
adjustment targets ke to maintain therapeutic concentrations.
Question 2
A pharmacist is evaluating a new sustained-release formulation of a narrow therapeutic
index drug. Which biopharmaceutical property is most critical to assess for bioequivalence?
A. Lipophilicity of the active ingredient
,B. Dissolution profile of the formulation
C. pKa of the conjugate base
D. Molecular weight of the excipient
Correct Answer: B
Explanation: For sustained-release products, dissolution rate governs absorption and
systemic exposure; bioequivalence requires comparable dissolution profiles to ensure
therapeutic equivalence and avoid toxicity.
Question 3
A patient receiving phenytoin develops nystagmus and ataxia. Serum phenytoin
concentration is 32 mcg/mL. Which pharmacokinetic principle best explains this toxicity?
A. First-order elimination with linear clearance
B. Zero-order elimination with saturated metabolism
C. Increased volume of distribution
D. Reduced protein binding
Correct Answer: B
Explanation: Phenytoin exhibits saturable (zero-order) metabolism at therapeutic doses;
small dose increases can produce disproportionate rises in serum concentration, leading to
toxicity.
Question 4
Which excipient is most appropriate for formulating an effervescent tablet intended to
dissolve rapidly in water?
A. Microcrystalline cellulose
,B. Sodium bicarbonate and citric acid
C. Magnesium stearate
D. Hydroxypropyl methylcellulose
Correct Answer: B
Explanation: Sodium bicarbonate and citric acid react in water to generate carbon dioxide,
producing effervescence that promotes rapid tablet disintegration and drug dissolution.
Question 5
A pharmacist calculates a creatinine clearance of 42 mL/min for a patient prescribed
gabapentin. Which dosing strategy is most appropriate?
A. Administer the standard dose more frequently
B. Administer a reduced dose at the same interval
C. Administer the standard dose at the same interval
D. Double the standard dose to saturate clearance
Correct Answer: B
Explanation: Gabapentin is eliminated unchanged by the kidney; moderate renal impairment
(CrCl 30–59 mL/min) requires dose reduction while maintaining the dosing interval to
prevent accumulation.
Question 6
A drug has a volume of distribution of 0.15 L/kg and is 95% protein-bound. Which statement
best describes its distribution?
A. Extensive tissue penetration due to high lipophilicity
, B. Limited distribution primarily confined to plasma
C. High brain penetration due to low protein binding
D. Accumulation in adipose tissue
Correct Answer: B
Explanation: A low volume of distribution (0.15 L/kg) combined with high protein binding
(95%) indicates the drug is largely confined to the vascular space, with minimal tissue
distribution.
Question 7
Which type of incompatibility is observed when a calcium-containing solution is mixed with
ceftriaxone in the same intravenous line?
A. pH-dependent hydrolysis
B. Physical precipitation
C. Oxidation-reduction reaction
D. Photodegradation
Correct Answer: B
Explanation: Ceftriaxone forms insoluble calcium-ceftriaxone precipitates when co-
administered with calcium-containing solutions, which can cause catheter occlusion and
potentially fatal embolic events.
Question 8
A pharmacist is compounding a nonsterile oral suspension. According to USP <795>, which
beyond-use date is appropriate for a water-containing formulation preserved with an
antimicrobial?
Pharmacotherapy, Medication Use, Patient Assessment, Evidence-
Based Treatment Planning, Professional Practice, Pharmacy
Management and Clinical Decision-Making
Questions 1–48: Foundational Knowledge for Pharmacy Practice
Question 1
A 68-year-old patient with a creatinine clearance of 28 mL/min is prescribed a renally
eliminated antibiotic. Which pharmacokinetic parameter most directly determines the
required dose adjustment?
A. Volume of distribution
B. Elimination rate constant
C. Bioavailability
D. Protein binding
Correct Answer: B
Explanation: The elimination rate constant (ke) reflects the fraction of drug removed per unit
time and is directly proportional to clearance, which is impaired in renal dysfunction; dose
adjustment targets ke to maintain therapeutic concentrations.
Question 2
A pharmacist is evaluating a new sustained-release formulation of a narrow therapeutic
index drug. Which biopharmaceutical property is most critical to assess for bioequivalence?
A. Lipophilicity of the active ingredient
,B. Dissolution profile of the formulation
C. pKa of the conjugate base
D. Molecular weight of the excipient
Correct Answer: B
Explanation: For sustained-release products, dissolution rate governs absorption and
systemic exposure; bioequivalence requires comparable dissolution profiles to ensure
therapeutic equivalence and avoid toxicity.
Question 3
A patient receiving phenytoin develops nystagmus and ataxia. Serum phenytoin
concentration is 32 mcg/mL. Which pharmacokinetic principle best explains this toxicity?
A. First-order elimination with linear clearance
B. Zero-order elimination with saturated metabolism
C. Increased volume of distribution
D. Reduced protein binding
Correct Answer: B
Explanation: Phenytoin exhibits saturable (zero-order) metabolism at therapeutic doses;
small dose increases can produce disproportionate rises in serum concentration, leading to
toxicity.
Question 4
Which excipient is most appropriate for formulating an effervescent tablet intended to
dissolve rapidly in water?
A. Microcrystalline cellulose
,B. Sodium bicarbonate and citric acid
C. Magnesium stearate
D. Hydroxypropyl methylcellulose
Correct Answer: B
Explanation: Sodium bicarbonate and citric acid react in water to generate carbon dioxide,
producing effervescence that promotes rapid tablet disintegration and drug dissolution.
Question 5
A pharmacist calculates a creatinine clearance of 42 mL/min for a patient prescribed
gabapentin. Which dosing strategy is most appropriate?
A. Administer the standard dose more frequently
B. Administer a reduced dose at the same interval
C. Administer the standard dose at the same interval
D. Double the standard dose to saturate clearance
Correct Answer: B
Explanation: Gabapentin is eliminated unchanged by the kidney; moderate renal impairment
(CrCl 30–59 mL/min) requires dose reduction while maintaining the dosing interval to
prevent accumulation.
Question 6
A drug has a volume of distribution of 0.15 L/kg and is 95% protein-bound. Which statement
best describes its distribution?
A. Extensive tissue penetration due to high lipophilicity
, B. Limited distribution primarily confined to plasma
C. High brain penetration due to low protein binding
D. Accumulation in adipose tissue
Correct Answer: B
Explanation: A low volume of distribution (0.15 L/kg) combined with high protein binding
(95%) indicates the drug is largely confined to the vascular space, with minimal tissue
distribution.
Question 7
Which type of incompatibility is observed when a calcium-containing solution is mixed with
ceftriaxone in the same intravenous line?
A. pH-dependent hydrolysis
B. Physical precipitation
C. Oxidation-reduction reaction
D. Photodegradation
Correct Answer: B
Explanation: Ceftriaxone forms insoluble calcium-ceftriaxone precipitates when co-
administered with calcium-containing solutions, which can cause catheter occlusion and
potentially fatal embolic events.
Question 8
A pharmacist is compounding a nonsterile oral suspension. According to USP <795>, which
beyond-use date is appropriate for a water-containing formulation preserved with an
antimicrobial?
